119 related articles for article (PubMed ID: 25769225)
1. Age-dependent vulnerability of cyclosporine-associated encephalopathy in children.
Chen LW; Chen JS; Tu YF; Wang ST; Wang LW; Tsai YS; Huang CC
Eur J Paediatr Neurol; 2015 Jul; 19(4):464-71. PubMed ID: 25769225
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine for acute encephalopathy with biphasic seizures and late reduced diffusion.
Watanabe Y; Motoi H; Oyama Y; Ichikawa K; Takeshita S; Mori M; Nezu A; Yokota S
Pediatr Int; 2014 Aug; 56(4):577-82. PubMed ID: 24418041
[TBL] [Abstract][Full Text] [Related]
3. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
Erer B; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Galimberti M; Giardini C; Gaziev D; Maiello A
Bone Marrow Transplant; 1996 Jul; 18(1):157-62. PubMed ID: 8832009
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
Wang Y; Zheng Y; Wen J; Ren J; Yuan X; Yang T; Hu J
Ital J Pediatr; 2021 Apr; 47(1):83. PubMed ID: 33794964
[TBL] [Abstract][Full Text] [Related]
5. Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.
Tsagalou EP; Anastasiou-Nana MI; Margari ZJ; Vassilopoulos D
J Heart Lung Transplant; 2007 Jun; 26(6):661-4. PubMed ID: 17543796
[TBL] [Abstract][Full Text] [Related]
6. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
Trullemans F; Grignard F; Van Camp B; Schots R
Eur J Haematol; 2001 Aug; 67(2):94-9. PubMed ID: 11722596
[TBL] [Abstract][Full Text] [Related]
7. [A clinical analysis of severe cyclosporine A-related neurotoxicity after allogenic hematopoietic stem cell transplantation].
Luo XD; Liu QF; Ning J; Fan ZP; Xu D; Wei YQ
Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):40-3. PubMed ID: 18346325
[TBL] [Abstract][Full Text] [Related]
8. Mesial temporal sclerosis--a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity.
Faraci M; Lanino E; Dallorso S; Morreale G; Cappelli B; Gaggero R; Dini G; Haupt R; Fondelli MP
Bone Marrow Transplant; 2003 May; 31(10):919-22. PubMed ID: 12748669
[TBL] [Abstract][Full Text] [Related]
9. Central neurotoxicity of cyclosporine in two children with nephrotic syndrome.
Taque S; Peudenier S; Gie S; Rambeau M; Gandemer V; Bridoux L; Bétrémieux P; De Parscau L; Le Gall E
Pediatr Nephrol; 2004 Mar; 19(3):276-80. PubMed ID: 14758527
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.
Iijima K; Hamahira K; Tanaka R; Kobayashi A; Nozu K; Nakamura H; Yoshikawa N
Kidney Int; 2002 May; 61(5):1801-5. PubMed ID: 11967030
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
[TBL] [Abstract][Full Text] [Related]
12. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome.
Fujinaga S; Kaneko K; Muto T; Ohtomo Y; Murakami H; Yamashiro Y
Arch Dis Child; 2006 Aug; 91(8):666-70. PubMed ID: 16670120
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
14. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting.
Al-Rasheed AK; Blaser SI; Minassian BA; Benson L; Weiss SK
Pediatr Neurol; 2000 Oct; 23(4):353-6. PubMed ID: 11068171
[TBL] [Abstract][Full Text] [Related]
16. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.
Yanagimachi M; Naruto T; Tanoshima R; Kato H; Yokosuka T; Kajiwara R; Fujii H; Tanaka F; Goto H; Yagihashi T; Kosaki K; Yokota S
Clin Transplant; 2010; 24(6):855-61. PubMed ID: 20030680
[TBL] [Abstract][Full Text] [Related]
17. Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation.
Teive HA; Brandi IV; Camargo CH; Bittencourt MA; Bonfim CM; Friedrich ML; de Medeiros CR; Werneck LC; Pasquini R
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):784-9. PubMed ID: 11593283
[TBL] [Abstract][Full Text] [Related]
18. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL
Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472
[TBL] [Abstract][Full Text] [Related]
19. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome.
Stârcea M; Gavrilovici C; Munteanu M; Miron I
J Int Med Res; 2018 Mar; 46(3):1172-1177. PubMed ID: 29310486
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin-A induced posterior reversible encephalopathy syndrome.
Saeed B; Abou-Zor N; Amer Z; Kanani I; Hilal M
Saudi J Kidney Dis Transpl; 2008 May; 19(3):439-42. PubMed ID: 18445907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
